We are live on ! Find out more
MCM

Matarin Capital Management Portfolio holdings

AUM $409M
1-Year Est. Return 33.03%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.87%
10 Year Est. Return
AUM
$1.4B
AUM Growth
+$23.7M
Cap. Flow
+$9.34M
Cap. Flow %
0.67%
Top 10 Hldgs %
12.1%
Holding
297
New
35
Increased
112
Reduced
76
Closed
41

Sector Composition

Rank Sector Weight
1 Industrials 17.51%
2 Financials 17.09%
3 Consumer Discretionary 13.86%
4 Healthcare 12.7%
5 Technology 12.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIGI icon
26
Selective Insurance
SIGI
$5.63B
$13.1M 0.94%
174,815
-3,574
-2% -$255K
ZD icon
27
Ziff Davis
ZD
$1.95B
$13.1M 0.93%
169,120
-5,970
-3% -$451K
XHR
28
Xenia Hotels & Resorts
XHR
$2.01B
$13M 0.93%
621,568
+5,489
+0.9% +$119K
WNC icon
29
Wabash National
WNC
$541M
$12.5M 0.9%
771,014
-119,034
-13% -$1.75M
SCS
30
DELISTED
Steelcase
SCS
$12.4M 0.89%
727,478
+6,145
+0.9% +$102K
MMI icon
31
Marcus & Millichap
MMI
$1.2B
$12.3M 0.88%
397,483
+67,215
+20% +$2.44M
ARCB icon
32
ArcBest
ARCB
$3.33B
$12.2M 0.87%
432,537
+3,464
+0.8% +$101K
RDUS
33
DELISTED
Radius Recycling
RDUS
$12.2M 0.87%
464,598
-48,003
-9% -$1.14M
ALGT icon
34
Allegiant Air
ALGT
$2.73B
$12.1M 0.87%
84,566
-4,236
-5% -$594K
CATM
35
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$12.1M 0.87%
443,681
+4,334
+1% +$141K
ARNA
36
DELISTED
Arena Pharmaceuticals Inc
ARNA
$12.1M 0.87%
+206,610
New +$10.7M
USNA icon
37
Usana Health Sciences
USNA
$429M
$12.1M 0.86%
151,772
+12,804
+9% +$1.02M
EVR icon
38
Evercore
EVR
$13.2B
$11.8M 0.85%
133,738
+22,888
+21% +$2.04M
CNR
39
Core Natural Resources Inc
CNR
$4.02B
$11.7M 0.84%
439,937
+150,414
+52% +$4.5M
PDM
40
Piedmont Realty Trust
PDM
$1.2B
$11.7M 0.83%
585,285
+5,013
+0.9% +$103K
HA
41
DELISTED
Hawaiian Holdings, Inc.
HA
$11.5M 0.82%
420,443
+3,404
+0.8% +$92.4K
ANIP icon
42
ANI Pharmaceuticals
ANIP
$1.84B
$11.5M 0.82%
139,783
+4,384
+3% +$312K
AMKR icon
43
Amkor Technology
AMKR
$11.3B
$11.5M 0.82%
1,537,019
+13,349
+0.9% +$104K
EGOV
44
DELISTED
NIC Inc
EGOV
$11.4M 0.82%
712,245
+27,307
+4% +$452K
EGRX
45
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$11.3M 0.81%
202,652
+73,707
+57% +$3.84M
AZPN
46
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$10.8M 0.77%
86,861
-15,227
-15% -$1.89M
WOR icon
47
Worthington Enterprises
WOR
$2.82B
$10.8M 0.77%
434,550
-52,042
-11% -$1.22M
HT
48
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$10.8M 0.77%
651,152
-125,127
-16% -$2.22M
AMCX icon
49
AMC Global Media
AMCX
$451M
$10.7M 0.77%
197,087
+1,584
+0.8% +$89.3K
CAKE icon
50
Cheesecake Factory
CAKE
$4.42B
$10.5M 0.75%
240,770
+1,081
+0.5% +$50.5K

Similar funds

Matarin Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Matarin Capital Management held 297 positions worth $1.4B, up 1.7% from $1.37B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Matarin Capital Management's Q2 2019 filing shows 35 new, 112 increased, 76 reduced and 41 closed positions. Its largest new stake was Arena Pharmaceuticals Inc: 206,610 shares worth $12.1M. The largest sale was Chesapeake Lodging Trust, an estimated $12.9M.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, down from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Matarin Capital Management's largest Q2 2019 buy was Arena Pharmaceuticals Inc: 206,610 shares worth $12.1M.
  • Matarin Capital Management added most to Alarm.com in Q2 2019, an estimated $7.68M increase.
  • Matarin Capital Management's biggest Q2 2019 reduction was Chesapeake Lodging Trust, cutting an estimated $12.9M.
  • Matarin Capital Management fully exited Saic in Q2 2019, selling an estimated $11.8M.
  • Matarin Capital Management's ten largest holdings make up 12% of its $1.4B portfolio in Q2 2019.
  • Matarin Capital Management opened 35 new positions and closed 41 in Q2 2019.
  • Matarin Capital Management's portfolio value rose 1.7% quarter-over-quarter to $1.4B.

Based on Matarin Capital Management's 13F filing for Q2 2019, filed 8 Aug 2019.